DXCM vs. META
DXCM (DexCom, Inc.) and META (Meta Platforms, Inc.) are both stocks. DXCM operates in Diagnostics & Research (Healthcare), while META operates in Internet Content & Information (Communication Services). Over the past 10 years, DXCM returned 13.66%/yr vs 16.39%/yr for META. Their 0.31 correlation means their historical movements had little consistent relationship.
Performance
DXCM vs. META - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DXCM achieves a 25.73% return, which is significantly higher than META's -15.51% return. Over the past 10 years, DXCM has underperformed META with an annualized return of 13.66%, while META has yielded a comparatively higher 16.39% annualized return.
DXCM
- 1D
- 11.95%
- 1M
- 21.19%
- 6M
- 14.25%
- YTD
- 25.73%
- 1Y
- 3.32%
- 3Y*
- -11.89%
- 5Y*
- -8.33%
- 10Y*
- 13.66%
- ALL TIME*
- 16.87%
META
- 1D
- 3.28%
- 1M
- -9.17%
- 6M
- -22.16%
- YTD
- -15.51%
- 1Y
- -27.79%
- 3Y*
- 20.28%
- 5Y*
- 9.53%
- 10Y*
- 16.39%
- ALL TIME*
- 20.02%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
DXCM DexCom, Inc. | $381.17M | $359.84M | $403.63M |
| $9.87B | $11.79B | $10.93B |
DXCM vs. META - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DXCM DexCom, Inc. | 25.73% | -14.66% | -37.33% | 9.58% | -15.64% | 45.23% | 69.02% | 82.59% | 108.75% | -3.87% |
META Meta Platforms, Inc. | -15.51% | 13.09% | 66.05% | 194.13% | -64.22% | 23.13% | 33.09% | 56.57% | -25.71% | 53.38% |
Correlation
The correlation between DXCM and META is 0.16, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.16 |
Correlation (3Y) Balances recent behavior with more history. | 0.21 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.34 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.33 |
Correlation (All Time) Calculated using the full available price history since May 18, 2012 | 0.31 |
The correlation between DXCM and META shifts across timeframes, from 0.16 (1 year) to 0.34 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
DXCM:
$32.20B
META:
$1.42T
DXCM:
$2.51
META:
$26.51
DXCM:
33.22
META:
21.00
DXCM:
0.79
META:
0.86
DXCM:
6.68
META:
6.27
DXCM:
12.47
META:
5.47
DXCM:
$4.97B
META:
$228.25B
DXCM:
$3.12B
META:
$186.59B
DXCM:
$1.41B
META:
$107.07B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DXCM vs. META — Risk / Return Rank
DXCM
META
DXCM vs. META - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DexCom, Inc. (DXCM) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DXCM | META | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.81 | ||
| Sortino ratioReturn per unit of downside risk | +1.32 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 0.89 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 0.10 | -0.84 | +0.94 |
| Martin ratioReturn relative to average drawdown | 0.19 | -1.52 | +1.71 |
Loading charts...
Drawdowns
DXCM vs. META - Drawdown Comparison
The maximum DXCM drawdown since its inception was -94.61%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for DXCM and META.
Loading charts...
Drawdown Indicators
| DXCM | META | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.61% | -76.74% | -17.87% |
Max Drawdown (1Y)Largest decline over 1 year | -33.33% | -33.30% | -0.03% |
Max Drawdown (3Y)Largest decline over 3 years | -60.95% | -34.15% | -26.80% |
Max Drawdown (5Y)Largest decline over 5 years | -66.32% | -76.74% | +10.42% |
Max Drawdown (10Y)Largest decline over 10 years | -66.32% | -76.74% | +10.42% |
Current DrawdownCurrent decline from peak | -48.75% | -29.30% | -19.45% |
Average DrawdownAverage peak-to-trough decline | -36.14% | -15.90% | -20.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.53% | 18.25% | -0.72% |
Volatility
DXCM vs. META - Volatility Comparison
DexCom, Inc. (DXCM) and Meta Platforms, Inc. (META) have volatilities of 15.95% and 15.37%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DXCM | META | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.95% | 15.37% | +0.58% |
Volatility (6M)Calculated over the trailing 6-month period | 29.74% | 30.29% | -0.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.91% | 39.78% | +3.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.22% | 44.68% | +2.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.66% | 39.10% | +9.56% |
Dividends
DXCM vs. META - Dividend Comparison
DXCM has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.38%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
DXCM DexCom, Inc. | 0.00% | 0.00% | 0.00% |
META Meta Platforms, Inc. | 0.38% | 0.32% | 0.34% |
Financials
DXCM vs. META - Financials Comparison
This section allows you to compare key financial metrics between DexCom, Inc. and Meta Platforms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DXCM vs. META - Profitability Comparison
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, DexCom, Inc. reported a gross profit of 830.00M and revenue of 1.31B. Therefore, the gross margin over that period was 63.4%.
META - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Meta Platforms, Inc. reported a gross profit of 49.47B and revenue of 60.80B. Therefore, the gross margin over that period was 81.4%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, DexCom, Inc. reported an operating income of 318.30M and revenue of 1.31B, resulting in an operating margin of 24.3%.
META - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Meta Platforms, Inc. reported an operating income of 18.78B and revenue of 60.80B, resulting in an operating margin of 30.9%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, DexCom, Inc. reported a net income of 249.10M and revenue of 1.31B, resulting in a net margin of 19.0%.
META - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Meta Platforms, Inc. reported a net income of 15.85B and revenue of 60.80B, resulting in a net margin of 26.1%.
Frequently Asked Questions
DXCM and META have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DXCM has higher volatility (15.95%) compared to META (15.37%). In terms of maximum drawdown, DXCM dropped -94.61% vs META's -76.74%.
DXCM currently has the higher Sharpe Ratio (0.08 vs -0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DXCM and META
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer